- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Wockhardt Hit With Rs 5 Crore Customs Penalty, Rs 10 Crore Redemption Fine Over API Misclassification

Mumbai: Wockhardt Limited has received an adjudication order from the Commissioner of Customs, Nhava Sheva-II, imposing a penalty of Rs 5 crore and a redemption fine of Rs 10 crore in connection with the alleged mis-classification of an Active Pharmaceutical Ingredient (API) exported by the company.
The Commissioner of Customs, NS-II, Centralized Adjudication Cell at Jawaharlal Nehru Custom House, Nhava Sheva, imposed the Rs 5 crore penalty under Section 114(iii) of the Customs Act, 1962.
In addition, the company has been directed to pay a redemption fine of Rs 10 crore in lieu of confiscation of the goods allegedly mis-declared by Wockhardt under Section 125(1) of the Customs Act, 1962.
Also Read: Wockhardt Gets CDSCO Nod for Antibiotic Zaynich in Complicated UTIs
The order also levied a penalty of Rs 1 crore on Dr Aravind Y Merwade, an officer of the company, under Section 114(iii) of the Customs Act in connection with the alleged mis-classification.
Wockhardt said it is confident about the merits of its case and is taking necessary steps to challenge the order through an appeal before the appropriate authority. The company stated that, apart from the monetary fine and penalties, the order would not have a material impact on its financials, operations or other activities.
Also Read: Wockhardt to exit US generic pharmaceutical segment
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

